Clinical Trial Update: 7-Keto DHEA for the Treatment of PTSD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating 7-Keto DHEA for PTSD, sponsored by Humanetics Corporation, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• 7-Keto DHEA (7-keto-dehydroepiandrosterone)

Snippet

Sponsor: Humanetics Corporation | Conditions: PTSD | Phase 2 | Status: COMPLETED